Results 101 to 110 of about 12,456 (182)

Targeting Na_v1.8 with the nonopioid antagonist suzetrigine for analgesia: cause for optimism? [PDF]

Br J Anaesth
Attal N, Barrot M.
europepmc   +1 more source

Naltrexone treatment improves anxiety- and depression-like behavior in alcohol-exposed mice. [PDF]

Behav Pharmacol
Yang S, Tong L, Zhang L, Cui R, Lyu X, He L, Liu H.   +6 more
europepmc   +1 more source

Strategies for treating acute pain in patients with opioid dependence: a scoping review protocol. [PDF]

BMJ Open
Levine S, Andrews M, Saracco B, Salzman M.   +3 more
europepmc   +1 more source

Immobilization of Polar and Brown bears using Etorphine and Xylazine [PDF]

, 1982
Gatesman, T., Wiesner, Henning
core  

Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer [PDF]

, 2015
Akihiro Yano, Hitoshi Masuda, Iwao Fukui, Junji Yonese, Shinya Yamamoto, Sho Uehara, Takeshi Yuasa, Yasuhisa Fujii   +7 more
core   +1 more source

Development of a Low-Barrier, Reimbursable Take-Home Naloxone Program at a Regional Health System. [PDF]

West J Emerg Med
London KS, Patel S, Lockstein D, Rashid J, Goodstein D, Pacitti R, Warrick-Stone T, Randolph F, Cherney A, Alexander K, Reed M.   +10 more
europepmc   +1 more source

Impact of Clinical Pharmacy Team Intervention on Naloxone Fills in Patients on ChroCnic Opioid Therapy. [PDF]

Perm J
Sijapati RS, Himes ER, Hale SA.
europepmc   +1 more source

Developments in the Study of Inert Gas Biological Effects and the Underlying Molecular Mechanisms. [PDF]

Int J Mol Sci
Tong MN, Li X, Cheng J, Jiang ZL.
europepmc   +1 more source

Enhanced spontaneous activity of the mu opioid receptor by cysteine mutations: characterization of a tool for inverse agonist screening. [PDF]

core   +1 more source

Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology. [PDF]

Psychopharmacol Bull
Naguy A, Alamiri B.
europepmc   +1 more source